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Abstract
Background: Hospitalization can significantly disrupt sleeping patterns. In consideration of the previous reports of
insomnia and apparent widespread use of benzodiazepines and other hypnotics in hospitalized patients, we conducted a
study to assess quality of sleep and hypnotic drug use in our acute care adult patient population. The primary objectives
of this study were to assess sleep disturbance and its determinants including the use of drugs with sedating properties.
Methods: This single-centre prospective study involved an assessment of sleep quality for consenting patients admitted
to the general medicine and family practice units of an acute care Canadian hospital. A validated Verran and Snyder-
Halpern (VSH) Sleep Scale measuring sleep disturbance, sleep effectiveness, and sleep supplementation was completed
daily by patients and scores were compared to population statistics. Patients were also asked to identify factors
influencing sleep while in hospital, and sedating drug use prior to and during hospitalization was also assessed.
Results: During the 70-day study period, 100 patients completed at least one sleep questionnaire. There was a relatively
even distribution of males versus females, most patients were in their 8th decade of life, retired, and suffered from
multiple chronic diseases. The median self-reported pre-admission sleep duration for participants was 8 hours and our
review of PharmaNetR profiles revealed that 35 (35%) patients had received a dispensed prescription for a hypnotic or
antidepressant drug in the 3-month period prior to admission. Benzodiazepines were the most common sedating drugs
prescribed. Over 300 sleep disturbance, effective and supplementation scores were completed. Sleep disturbance scores
across all study days ranged 16–681, sleep effectiveness scores ranged 54–402, while sleep supplementation scores
ranged between 0–358. Patients tended to have worse sleep scores as compared to healthy non-hospitalized US adults
in all three scales. When compared to US non-hospitalized adults with insomnia, our patients demonstrated sleep
disturbance and supplementation scores that were similar on Day 1, but lower (i.e. improved) on Day 3, while sleep
effectiveness were higher (i.e. better) on both days. There was an association between sleep disturbance scores and the
number of chronic diseases, the presence of pain, the use of bedtime tricyclic antidepressants, and the number of chronic
diseases without pain. There was also an association between sleep effectiveness scores and the length of hospitalization,
the in hospital use of bedtime sedatives and the presence of pain. Finally, an association was identified between sleep
supplementation scores and the in hospital use of bedtime sedatives (tricyclic antidepressants and loxapine), and age.
Twenty-nine (29%) patients received a prescription for a hypnotic drug while in hospital, with no evidence of pre-
admission hypnotic use. The majority of these patients were prescribed zopiclone, lorazepam or another benzodiazepine.
Conclusions: The results of this study reveal that quality of sleep is a problem that affects hospitalized adult medical
service patients and a relatively high percentage of these patients are being prescribed a hypnotic prior to and during
hospitalization.
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Background
Sleep is essential for health and quality of life. [1] Insom-
nia is a subjective complaint of dissatisfaction with the
quantity, quality or timing of sleep. [2,3] This disorder is
estimated to occur in approximately 12% to 25% of the
general population, although this is probably an underes-
timate as there is evidence that many adults do not report
their sleep problems to a health care professional. [4,5] It
is well recognized that hospitalization can significantly
disrupt sleeping patterns. [3,6,7] In hospitalized patients,
the most common causes of acute insomnia include the
effects of illness, environmental sleep disruption, medica-
tion, anxiety, and depression. Investigators have shown
that insomnia in the hospitalized patient leads to
increased fatigue, irritability, and aggressiveness as well as
decreased pain tolerance. [3]
Treatment of insomnia in the institutional setting is gen-
erally aimed at correcting underlying medical disorders,
reducing environmental sleep disruptions, and lowering
anxiety with psychological interventions and relaxation
training or pharmacotherapy. [8]
Benzodiazepines are the most common drugs used for the
pharmacological management of acute insomnia in both
institutionalized and ambulant patients. [9-20] Of the
available agents, short and intermediate-acting benzodi-
azepines such as lorazepam and oxazepam have become
the most commonly prescribed for this indication. While
these agents have proven to be efficacious and relatively
safe, benzodiazepines are associated with a multitude of
adverse effects which are most commonly observed with
higher doses and prolonged use. [11] Common side
effects include residual daytime sedation ("hangover"),
anterograde amnesia, and respiratory depression. [9]
Rebound insomnia has also been associated with benzo-
diazepines. Tolerance to the hypnotic effects of the short
and intermediate-acting agents can develop within one to
two weeks of use and abrupt discontinuation can result in
withdrawal symptoms such as anxiety, confusion, disori-
entation, insomnia, and perceptual changes. [9] Benzodi-
azepines have been frequently implicated in drug-
associated hospital admissions. [11] Non-benzodi-
azepine hypnotics are now receiving attention as alterna-
tives to our traditional armamentarium for the treatment
of insomnia. In addition to new agents such as zopiclone,
zolpidem, and zaleplon, nonprescription products such
as diphenhydramine, doxylamine, and melatonin appear
to be potential alternatives for short-term use. [17]
Sleep quality in a hospitalized patient can be measured by
a variety of methods including the use of movement mon-
itoring devices, brain electrical activity, sleep diaries and
sleep scales. A sleep scale is an effective method of objec-
tively determining the quality of sleep in hospitalized
patients. The Verran and Snyder-Halpern (VSH) Sleep
Scale represents one such scale that has been used to
measure sleep quality in hospitalized patients [3,7,21].
This validated scale encompasses the different parameters
of sleep such as sleep disturbances, number of awaken-
ings, difficulty in falling asleep and time spent sleeping is
a valuable instrument.
In consideration of the previous reports of insomnia and
apparent widespread use of benzodiazepines and other
hypnotics in hospitalized patients, we conducted a study
to assess quality of sleep (as defined by the VSH Sleep
Scale) and hypnotic drug use in our acute care adult
patient population. The primary objectives of this study
were to assess sleep disturbance and its determinants
including the use of drugs with sedating properties. The
secondary objectives of this study included an assessment
of the degree of sleep effectiveness and supplementation
and their determinants. Finally, a comparison of our
study patient results to previously published results in dif-
ferent patient samples was conducted.
Methods
This study was conducted at an 800-bed adult tertiary
care, Canadian teaching institution over a 70-day period
(February – April 2001). The study received university eth-
ics committee and hospital research committee approvals
prior to initiation.
Patients
Adult patients who were admitted to the general medicine
or family practice wards during the study period were con-
sidered eligible for the study. Inclusion criteria for
enrollment included age (18 years or older), ability to
complete the sleep assessment questionnaires and a will-
ingness to provide written informed consent. For each
patient, the ability to complete the sleep questionnaires
was assessed by one of the study investigators through a
review of the health record (to assess past medical history,
history of present illness, reason for admission and Eng-
lish language skills) and discussion with members of the
primary health care team.
Data collection and schedule of evaluation
Upon enrollment, consenting patients were interviewed
using a subject information questionnaire (please see
additional file, Appendix 1) to capture information per-
taining to patient demographics, pre-admission sleep
characteristics and pre-admission use of sedating drugs at
or around bedtime. Patients were explicitly asked to pro-
vide information as to whether their illness had led to
sleep loss or disruption in normal sleep times during the
last two months; whether they had any routine assistance
for achieving sleep; whether they had (or were planning
to) work a night shift with daytime sleeping within theHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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last two months and whether or not they were currently
experiencing any stress which might disrupt their normal
sleep patterns.
Each patient was then requested to complete a daily ques-
tionnaire (commencing on the day of enrollment) con-
taining the VSH Sleep Scale and questions regarding sleep
disturbances and potential adverse reactions to any sedat-
ing drugs administered during hospitalization (please see
additional file, Appendix 2). Using this questionnaire,
patients provided an assessment of the quality of their
previous night's sleep. Finally, patients were also asked to
identify three potential causes of sleep disruption accord-
ing to causes that we previously identified from the litera-
ture. These included pain, shortness of breath, or having
to use the washroom that resulted in awakening.
In an attempt to improve the accuracy of their recollec-
tion, patients were requested to complete their sleep
assessments for the previous 24 hours before 1200 hrs on
the next day. When necessary, the investigators responded
to patient requests to clarify questions and/or assisted
with the physical marking of the sleep scale. No attempt
was made to influence the response to any question.
Patients were requested to complete the daily sleep ques-
tionnaires until discharge or withdrawn from the study.
Measurement of sleep quality
The VSH Sleep Scale utilizes three scales (sleep distur-
bance, sleep effectiveness, and sleep supplementation) to
characterize overall sleep quality. [3] Psychometric testing
of this sleep scale has been conducted in ambulatory and
hospitalized patient populations. [22] Sleep quality (as
measured by the sleep disturbance scale) was considered
the primary study outcome parameter. The sleep distur-
bance scale characterizes sleep fragmentation and latency
as measured by seven sleep properties. Fragmentation
characteristics include mid-sleep awakening, wake after
sleep onset, movement during sleep, soundness of sleep,
and quality of disturbance while latency characteristics
include sleep latency and quality of latency. Each charac-
teristic is measured using a 100 mm visual analogue scale
and the total score for the primary outcome of sleep dis-
turbance is a sum of the scores from each scale (total score
maximum 700). A lower total score on this scale indicates
a lower degree of sleep disturbance. [3]
The secondary outcome parameters for this study
included the degree of sleep effectiveness and sleep sup-
plementation (and their determinants) as measured by
the VSH Sleep Scale. The sleep effectiveness scale meas-
ures both quality and length of sleep as perceived by the
patient using the following five characteristics: rest upon
awakening, subjective quality of sleep, sleep sufficiency
evaluation, total sleep time, and total sleep period. A vis-
ual analogue scale is used to measure each of the five
items and these scores are summed to represent a total
score. The maximum possible total score is 500 with a
higher score representing greater sleep effectiveness. [3]
The sleep supplementation scale measures the degree to
which the bulk sleep period is augmented with additional
sleep time. The four characteristics measured are daytime
sleep, morning sleep, afternoon sleep, and wake after final
arousal. The scores from each of these scales are summed
to obtain a total score (total score maximum 400). In
addition, the total sleep period is calculated by adding the
scores from wake after sleep onset and total sleep time. A
higher total score on this scale represents a worse out-
come, as more supplemental sleep was needed. [3]
Drug use assessment
During hospitalization, information regarding adminis-
tration of hypnotic drugs or other medications that may
have affected sleep was extracted by the investigators from
the health record and confirmed through discussions with
the health care team and patient. This information was
recorded using a standard data collection form.
To augment self-reported information regarding pre-
admission drug use, we accessed a provincial community
prescription database (PharmaNetR) to identify prescrip-
tion hypnotics (benzodiazepines or zopiclone) and anti-
depressants (any class) that had been dispensed by a
pharmacy during the 3-month period prior to admission.
Statistical analysis
A sample of 100 patients with one or more completed
sleep questionnaires was considered to be adequate for
the purpose of characterizing the quality of sleep and its
determinants based on previous studies and the analytic
methods employed. Descriptive analyses of patient demo-
graphics, hypnotic use, drugs influencing sleep, sleep dis-
turbing factors, and sleep scale scores were undertaken
using SPSS version 10.0.
Due to the correlated nature of the repeated VSH Sleep
Scale observations in each participant, generalized esti-
mating equations (GEE) using the identity link were uti-
lized to model the scores on each of the scales (dependent
variable) and possible predictors. The selection of predic-
tors began with a univariate analysis of all variables that
were identified a priori as being potential predictive factors
for each dependent variable. Those variables with a p-
value  ≤ 0.10 were retained for inclusion in the final
model. Regression co-efficients (β) and standard errors
(SE) are reported for each association. Model fit was
assessed by the closeness to 1.0 of the deviance statistic
divided by its degrees of freedom. We used SAS version
8.0 (SAS Institute, Inc., Cary, North Carolina), for allHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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inferential statistical analyses. All p-values were derived
from two-sided hypothesis tests and were unadjusted for
multiple comparisons. Plots of the residuals were exam-
ined to determine if the assumptions of regression were
violated.
To assess differences in quality of sleep between our study
participants and other populations, mean sleep score
results for study days 1 and 3 were compared to normative
data published by Verran and Snyder-Halpern [22] for
102 healthy adults (65% female, mean age 39.5 years (SD
10.4)) and adults with insomnia (73% female, 45.5 years
(SD16.1)) in their usual sleep environment in the United
States.
Results
During the study period, health records were screened for
295 consecutively admitted patients to determine poten-
tial study eligibility. Of these patients, 193 were excluded
due to severity of illness or language barriers that were
considered by the investigators to seriously impede the
patient's ability to provide informed consent and com-
plete the sleep questionnaires. Of the 102 patients
enrolled into the study, two patients were unable to com-
plete any sleep questionnaires. The remaining 100
patients completed at least one questionnaire. These par-
ticipants were typically enrolled in the study within the
first few days of admission (median 3 days (range 0–27)),
while enrollment was occasionally delayed for those who
were transferred from another service.
Patient demographics, pre-admission sleep characteristics
and sedative drug use are shown in Table 1. There was a
relatively even distribution of males versus females, and
patients were typically in their 8th decade of life, retired
and diagnosed with multiple documented chronic dis-
eases. The five most commonly recorded chronic diseases
were hypertension (18% of patients), depression (14%),
CVA (12%), COPD (10%) and CHF (9%). The five most
commonly recorded chief complaints resulting in hospi-
talization were GI bleed/ulcer (15%), CHF (9%), pneu-
monia (8%), atrial fibrillation (3%) and angina (3%).
The median self-reported pre-admission sleep duration
for participants was 8 hours and less than 30% of patients
claimed to use sedating drugs on or around bedtime prior
to admission.
Sleep disturbance, effectiveness and supplementation
Three hundred and thirty-two sleep disturbance, 308
sleep effectiveness scores, and 332 sleep supplementation
were completed by the participants during the study
period. Sleep disturbance scores across all study days
ranged 16 – 681, sleep effectiveness scores ranged 54 –
402, while sleep supplementation scores ranged between
0 – 358.
When mean quality of sleep scores for Day 1 (100
patients) and Day 3 (52 patients) were compared with
normative published data for healthy and insomniac
adults in their usual sleep environment, our patients
tended to have worse sleep scores as compared to healthy
non-hospitalized US adults in all three scales (Figure 1).
Conversely, when compared to US non-hospitalized
adults with insomnia, our patients demonstrated sleep
disturbance and supplementation scores that were similar
on Day 1, but lower (i.e. improved) on Day 3, while sleep
effectiveness were higher (i.e. better) on both days.
The results of the GEE regression analysis are presented in
Table 2. There was an association between sleep distur-
bance scores and the number of chronic diseases, the pres-
ence of pain, the use of bedtime tricyclic antidepressants,
and the number of chronic diseases without pain. There
was an association between sleep effectiveness scores and
the length of hospitalization, the in hospital use of bed-
time sedatives and the presence of pain. Finally, there was
an association between sleep supplementation scores and
the in hospital use of bedtime sedatives (tricyclic antide-
pressants and loxapine), and age. There was no associa-
tion between sleep scores and the other variables
investigated.
Drug use assessment
Twenty-nine (29%) patients reported using a sedating
drug at or around bedtime while at home. According to
our review of PharmaNetR profiles for these patients, 35
Table 1: Patient demographics
Parameter (N = 100) Value
Gender (%)
Male 41
Female 59
Ward (%)
General Medicine Ward 42
Family Practice Ward 58
Mean age, yrs (range) 75 (35 – 97)
Median number of chronic diseases (range) 3.0 (0 – 7)
Median duration of sleep at home, hrs (range) 8 (1 – 14)
Employment status (%)
Retired 79
Unemployed 8
Part-time employment 4
Full-time employment 9
Sedative use at home (%)
Yes 29
No 71Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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(35%) patients had actually received a dispensed prescrip-
tion for a hypnotic or antidepressant drug in the 3-month
period prior to the current admission. Benzodiazepines
were the most common class of sedating drug prescribed
(Figure 2). A PharmaNetR profile was not available for
four (4%) patients.
Hypnotic agents
Thirty-six (36%) patients did not have a hypnotic pre-
scribed prior to or during hospitalization. Thirty-one
(31%) patients had a continuation of their pre-admission
hypnotic prescription while in hospital, whereas another
four (4%) patients had their pre-admission hypnotic dis-
continued while in hospital. Finally, 29 (29%) patients
had a hypnotic prescription initiated in hospital, with no
evidence of pre-admission hypnotic use.
Overall, 60 (60%) patients were prescribed zopiclone or a
benzodiazepine for bedtime hypnotic use while in hospi-
tal (Figure 3). Lorazepam was the most popular hypnotic
prescribed followed by zopiclone, oxazepam, clon-
azepam, alprazolam, temazepam, or a combination of
agents.
Other drugs with sedating properties
Patients were also prescribed a variety of other sedating
drugs at bedtime during their hospitalization. Figure 4
depicts the classes of drugs used as a percentage of the
total patient observations recorded. Of those who
received a hypnotic the night prior to filling out a ques-
tionnaire, 68 (20%) of observations revealed the admin-
istration of a benzodiazepine while 37 (11%) revealed the
administration of zopiclone. Other notable drugs with
sedating properties that were used at bedtime included
antidepressants, antipsychotics, antinauseants and nar-
cotic analgesics.
Discussion
This study was designed to provide an objective measure
of the quality of sleep and its predictive factors for hospi-
talized adult patients at our institution. Our results show
that these inpatients have significant impairment in all
sleep scales, and a quality of sleep that is inferior to non-
institutionalized healthy adults and almost as impaired as
insomniacs. Although predictors varied across scales, bed-
time sedative use was consistently associated (either posi-
tively or negatively, depending on the agent) with sleep
outcomes. Sixty percent of our patients received a pre-
scription for a bedtime hypnotic. Thus, it would appear
that despite widespread sedative drug use in the hospital,
Comparison of VSH Sleep Dimensions1 Figure 1
Comparison of VSH Sleep Dimensions (data represents mean VSH scores for each sleep dimension).Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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patients still experience sleep impairment. Zopiclone was
found to be beneficial for sleep disturbance, but
detrimental for sleep effectiveness and supplementation
relative to other sedative drugs including
benzodiazepines.
Previous investigations have revealed that the most com-
mon factors affecting sleep in hospitalized patients
include the effects of illness, environmental sleep disrup-
tion, additional medication, anxiety, and depression
[3,6,7]. Insomnia in the hospitalized patient leads to
increased fatigue, irritability and aggressiveness as well as
decreased pain tolerance. [3] We found that sleep distur-
bance was explained by the number of chronic diseases,
presence of pain, bedtime sedative use and an interaction
term between pain and number of chronic diseases. Of
interest, we had expected that as the number of chronic
diseases increased, the sleep disturbance score would also
increase. However, we found the opposite and are unable
to explain this observation. This is further complicated by
the interaction term that found that chronic diseases with
pain are associated with a decrease in sleep disturbance.
Potentially, this could be confounded by the use of nar-
cotic agents (i.e. narcotics would be expected to alleviate
Table 2: Relationship between sleep subscales and predictive factors
95% CI
Factor β coefficient Lower Upper p-value
Sleep disturbance subscale*
Sleep loss/disruption due to illness
Yes 48 -7.83 105.01 0.092
No (reference) 0 0 0
# of chronic diseases -30.33 -46.78 -13.88 0.0003
Pain
Yes (reference) 0 0 0
No -135 -218.31 -51.71 0.0015
Bedtime sedative <0.0001
None 57.33 -13.48 128.15 0.11
Benzodiazepines 60.75 -12.87 134.4 0.11
Tricyclic antidepressants 250.73 189.25 312.22 <0.0001
Loxapine 16.24 -94.09 126.57 0.77
Zopiclone (reference) 0 0 0
# of chronic disease without pain 27.16 3.51 50.81 0.024
# of chronic disease with pain (reference) 0 0 0
Sleep supplementation subscale
Age (by year) -1.88 -3.07 -0.7 0.0018
Bedtime sedative <0.0001
None -18.12 -54.66 18.41 0.33
Benzodiazepines -39.55 -83.68 4.58 0.079
Tricyclic antidepressants -57.82 -92.51 -23.13 0.0011
Loxapine 2.92 -112.48 118.33 0.96
Zopiclone (reference) 0 0 0
Sleep effectiveness subscale
Day of hospitalization -2.65 -4.88 -0.43 0.02
Bedtime sedative 0.0031
None 33.8 16.24 51.36 0.0002
Benzodiazepines 32.82 13.87 51.78 0.007
Tricyclic antidepressants 29.74 13.47 46.02 0.0003
Loxapine 20.18 4.35 36.01 0.013
Zopiclone (reference) 0 0 0
Pain
Yes (reference) 0 0 0
No -15.76 -30.04 -1.47 0.031
* Scaled deviance value divided by its degrees of freedom = 1.03 $ Scaled deviance value divided by its degrees of freedom = 1.02 # Scaled deviance 
value divided by its degrees of freedom = 1.02Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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pain and may induce sleep) within the hospital. Further
investigation into these results is warranted. For the sleep
supplementation scale, increasing age was associated with
less supplementation. This may be because older people
generally require less sleep. For sleep effectiveness, length
of hospitalization resulted in lower scores. Thus, for
patients with prolonged duration of hospital stay, special
attention should be paid to their sleep patterns. Pain was
associated with a better sleep effectiveness score (opposite
to its impact on sleep disturbance). Again, this result
could be confounded by the use of narcotic agents in the
hospital.
Tranmer et al [21] recently assessed the sleep experience of
medical and surgical patients during their stay in a Cana-
dian teaching hospital using the Verran and Snyder –
Halpern sleep scale. When scores for the 54 medical
patients in this study were adjusted for visual analogue
scale differences, it is apparent that our study patients gen-
erally had reported more sleep disturbance, greater sleep
effectiveness and similar sleep supplementation needs.
This was likely related to differences in the patient popu-
lations (e.g. patients in this recent study tended to be
younger, predominantly male and from a limited
selection of diagnostic groups) as well as differences in the
physical environments between the two study settings.
Similar to Tranmer et al, we found an association between
Pre-admission hypnotic and antidepressant use1 Figure 2
Pre-admission hypnotic and antidepressant use (35 patients (35%) were prescribed a hypnotic or antidepressant during the 3-
month period prior to admission according to our review of PharmaNetR records).
Benzo
63%
Antidepressant
14%
Benzo combo
3%
Zopiclone
9%
Unknown
11%Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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sleep quality and a number of internal and external fac-
tors. In both studies, patients with longer hospital stays
tended to report better sleep, likely reflecting an increased
familiarity with the new surroundings. Older patients and
those with pain had a poorer quality of sleep.
According to our analysis, approximately one-third of
patients used a hypnotic prior to admission and contin-
ued therapy during hospitalization for the treatment of
insomnia. This observation was not surprising consider-
ing the prevalence of insomnia (~25%) in the general
population [2]. Sixty percent of patients received a pre-
scription for a hypnotic while in hospital and about one-
half of these appear to have been hypnotic-naïve patients.
This finding is consistent with observations published in
a 2002 report by Ramesh and Roberts [20]. These investi-
gators assessed inpatient and discharge prescribing of ben-
zodiazepines used for sleep induction in two Indian
Distribution of hypnotic drugs prescribed during hospitalization1 Figure 3
Distribution of hypnotic drugs prescribed during hospitalization (N = 60 patients including 31 (31%) patients had a continuation 
of their pre-admission hypnotic prescription while in hospital and 29 (29%) patients had a hypnotic prescription initiated in hos-
pital with no evidence of pre-admission hypnotic use).
Lorazepam & 
Zopiclone
2%
Lorazepam
35%
Temazepam
2%
Oxazepam & 
Lorazepam
6%
Alprazolam
4%
Oxazepam
16%
Clonazepam
6%
Zopiclone
29%Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/17
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medical wards over a 3-month period and found that 57%
of those patients prescribed benzodiazepines in hospital
were not taking a benzodiazepine at home prior to admis-
sion. Approximately one in three inpatients in our study
received a benzodiazepine during admission and this
finding is also similar to that reported in 2001 by Elliott
et al [19]. Accordingly, it appears that hypnotic agents
continue to be widely used in our hospitalized medical
patient population and benzodiazepines remains the
most commonly prescribed hypnotic drug class for this
purpose.
There are several limitations associated with this study.
Foremost, we screened 295 patients in order to recruit 100
participants. As such, it is possible, by applying our inclu-
sion/exclusion criteria, that we selected people with less
serious sleep deficits. This could potentially bias our
results and affect the generalizability of our findings.
However, we believe that this is a conservative bias in that
we still found a significant proportion and degree of sleep
deficits in our sample. While most patients were enrolled
within a few days of hospitalization, enrollment was
delayed for others and this may have influenced their
quality of sleep scores. No attempt was made to directly
assess this potential relationship. We relied on patient rec-
ollection of sedating drug use prior to admission. Hyp-
notic use prior to hospitalization was confirmed by a
PharmaNetR  review; however, over-the-counter and
Drugs with sedating properties prescribed for bedtime administration during hospitallization1 Figure 4
Drugs with sedating properties prescribed for bedtime administration during hospitalization (percentage based upon 339 
observations).
No
36%
Benzo
20%
Other combo
18%
Antinauseant
1%
Benzo + Zopiclone
2%
Benzo combo
1%
Narcotic
2%
Antipsychotic
4%
Antidepressant
5%
Zopiclone
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herbal hypnotic agents purchased without a prescription
are not captured by this database. For the purposes of
quality of sleep comparisons with non-hospitalized
patients, we relied on quality of sleep scores reported for
a younger, predominantly female sample group. [22]
Accordingly, it is not possible to conclude with any cer-
tainty that institutionalization alone accounted for a dif-
ferent in sleep quality between these two groups. Finally,
this study involved patients in the general medicine and
family practice areas of this hospital only; thus, we cannot
extrapolate our results to the general hospital population.
The results of this study reveal that quality of sleep is a
problem that affects hospitalized adult medical service
patients and a relatively high percentage of these patients
are being prescribed a hypnotic prior to and during
hospitalization.
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